These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6985697)

  • 1. Molsidomine in the treatment of patients with angina pectoris.
    Majid PA; DeFeyter PJ; Van der Wall EE; Wardeh R; Roos JP
    N Engl J Med; 1980 Jan; 302(1):1-6. PubMed ID: 6985697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ergometric study of a new vasodilator agent in angina: molsidomine. Value of combination with beta-blockaders].
    Witchitz S; Kolsky H; Moisson P; Valette H
    Arch Mal Coeur Vaiss; 1981 Apr; 74(4):463-71. PubMed ID: 6112971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of long-term molsidomine treatment versus isosorbide dinitrate and placebo on exercise tolerance in stable angina.
    Romano M; de Caprio L; Meccariello P; Cuomo S; Baldini F; D'Ascia C; Steinberg G; Chiariello M
    Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):246-9. PubMed ID: 6430811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molsidomine in ergometric tests (author's transl)].
    Röhl D; Lehmann KH
    Dtsch Med Wochenschr; 1980 Aug; 105(35):1216-9. PubMed ID: 6893580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of molsidomine on global and regional left ventricular function at rest and during exercise in patients with angina pectoris.
    Nechwatal W; Stauch M; Sigel H; Kress P; Bitter F; Geffers H; Adam WE
    Clin Cardiol; 1981; 4(5):248-53. PubMed ID: 6895491
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of multicenter clinical trial of molsidomine by single-blind method in stable angina pectoris].
    Jasiński K; Lukasik S; Poprawski K; Wrabec K; Nowosad H; Kargul W
    Kardiol Pol; 1981; 24(5):397-405. PubMed ID: 7021947
    [No Abstract]   [Full Text] [Related]  

  • 7. Hemodynamic effects of molsidomine at rest and during submaximal and maximal exercise in patients with coronary artery disease limited by exertional angina pectoris.
    Detry JM; Melin J; Brasseur LA; Cosyns J; Rousseau MF
    Am J Cardiol; 1981 Jan; 47(1):109-15. PubMed ID: 6893896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect duration and dose-response relation of molsidomine in patients with coronary heart disease].
    Fach WA; Becker HJ
    Z Kardiol; 1984 Oct; 73(10):613-22. PubMed ID: 6393621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and hemodynamic effects of the new dilator drug molsidomine.
    Malcolm AD
    Am Heart J; 1985 Mar; 109(3 Pt 2):674-7. PubMed ID: 3883734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of molsidomine on left ventricular function in coronary heart disease (author's transl)].
    Meyer J; Sprauer R; Krebs W; Erbel R; Schweizer P; Effert S
    Dtsch Med Wochenschr; 1980 Aug; 105(35):1210-6. PubMed ID: 6893579
    [No Abstract]   [Full Text] [Related]  

  • 11. [The effect of molsidomin on the arterial windkessel (author's transl)].
    Sauer G; Tebbe U; Krause H; Kreuzer H; Neuhaus KL
    Z Kardiol; 1981 Sep; 70(9):713-8. PubMed ID: 6895435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-ischemic effect of 8 mg molsidomin in retard form].
    Blasini R; Brügmann U; Rudolph W
    Herz; 1984 Dec; 9(6):346-52. PubMed ID: 6392050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of molsidomine in the long-term treatment of exertional angina pectoris and chronic congestive heart failure.
    Rudolph W; Dirschinger J
    Am Heart J; 1985 Mar; 109(3 Pt 2):670-4. PubMed ID: 3883733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penbutolol and molsidomine synergism in angina pectoris. A double blind ergometric trial.
    Balestrini AE; Menzio AC; Cabral R; Feldman R; Mercogliano C; Flichtentrei D; Albera HP; Vazquez A
    Eur J Clin Pharmacol; 1984; 27(1):1-5. PubMed ID: 6386486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic effects of molsidomine.
    Rakovec P
    J Cardiovasc Pharmacol; 1980; 2(6):893-4. PubMed ID: 6160337
    [No Abstract]   [Full Text] [Related]  

  • 16. [Molsidomine: evaluation of a single dose using the exercise test].
    Ruano J; Zueco J; Colman T; López C; Pajarón A
    Rev Esp Cardiol; 1985; 38(2):93-7. PubMed ID: 3890039
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacological basis of therapy with molsidomine].
    Bassenge E
    Herz; 1982 Oct; 7(5):296-306. PubMed ID: 6897544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An improved exercise test in coronary-heart disease: effect of molsidomin on erogometrically controlled exercise (author's transl)].
    Blazek G; Heeger H; Kubicek F
    Dtsch Med Wochenschr; 1977 Jan; 102(3):81-4. PubMed ID: 832584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind, randomized, placebo-controlled study of molsidomine in patients with stable effort angina receiving beta-blocker therapy with atenolol.
    De Backer GG; Derese A
    Am Heart J; 1985 Mar; 109(3 Pt 2):678-81. PubMed ID: 3883735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical and hemodynamic effect of molsidomine in patients with unstable angina pectoris].
    Beloev I; Tomov I; Elenkova A; Terzieva L
    Vutr Boles; 1982; 21(3):62-9. PubMed ID: 6810552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.